Distal nephron function in patients receiving chronic lithium therapy. Renal tubular function was studied in 14 patients chronically treated with lithium for affective disorders. Patients were separated into two groups according to the duration of lithium therapy: long-term (35 ± 7.0 months) and short-term (4.8 ± 0.8 months). At comparable urine lithium concentrations, patients on long-term therapy had a lower maximal urine osmolality (Umax) and free water reabsorption (TcH2O) than did patients on short-term therapy. The latter group achieved a Umax above 800mOsm kg H2O. In contrast, both groups of patients failed to increase the urine-blood (U-B) PCO2 gradient normally during acute sodium bicarbonate loading. This low U-B PCO2 was observed...
Previous reports identify a voltage dependent distal renal tubular acidosis (dRTA) secondary to lith...
Lithium treatment reduces the renal kallikrein excretion rate. Lithium salts are widely used agents ...
Lithium is the drug that is most frequently associated with acquired nephrogenic diabetes insipidus ...
Renal function and biopsy findings in patients on long-term lithium treatment. Nine patients on long...
Lithium-induced impairment of urine acidifcation. The purpose of this study was to clarify the means...
Background. Lithium is the most effective drug for mood stabilization in bipolar disorder. However, ...
The renal risks associated with long-term lithium treatment are a growing concern. We have therefore...
Lithium (Li) carbonate has been reported to be able to cause some reversible functional changes in t...
Distal nephron function of the rat during lithium chloride infusion.Chronic lithium (Li) administrat...
Forty-six lithium (Li) patients who had been on Li for about 1–11 years were studied while on Li and...
Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion ...
Aims. To investigate the prevalence and clinical implications of renal and parathyroid morbidity in ...
Ten patients on long term lithium therapy (mean four years, range 1-10.5 years) were subjected to va...
Lithium therapy’s most common side effects affecting the kidney are nephrogenic diabetes insipidus (...
Lithium treatment reduces the renal kallikrein excretion rate. Lithium salts are widely used agents ...
Previous reports identify a voltage dependent distal renal tubular acidosis (dRTA) secondary to lith...
Lithium treatment reduces the renal kallikrein excretion rate. Lithium salts are widely used agents ...
Lithium is the drug that is most frequently associated with acquired nephrogenic diabetes insipidus ...
Renal function and biopsy findings in patients on long-term lithium treatment. Nine patients on long...
Lithium-induced impairment of urine acidifcation. The purpose of this study was to clarify the means...
Background. Lithium is the most effective drug for mood stabilization in bipolar disorder. However, ...
The renal risks associated with long-term lithium treatment are a growing concern. We have therefore...
Lithium (Li) carbonate has been reported to be able to cause some reversible functional changes in t...
Distal nephron function of the rat during lithium chloride infusion.Chronic lithium (Li) administrat...
Forty-six lithium (Li) patients who had been on Li for about 1–11 years were studied while on Li and...
Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion ...
Aims. To investigate the prevalence and clinical implications of renal and parathyroid morbidity in ...
Ten patients on long term lithium therapy (mean four years, range 1-10.5 years) were subjected to va...
Lithium therapy’s most common side effects affecting the kidney are nephrogenic diabetes insipidus (...
Lithium treatment reduces the renal kallikrein excretion rate. Lithium salts are widely used agents ...
Previous reports identify a voltage dependent distal renal tubular acidosis (dRTA) secondary to lith...
Lithium treatment reduces the renal kallikrein excretion rate. Lithium salts are widely used agents ...
Lithium is the drug that is most frequently associated with acquired nephrogenic diabetes insipidus ...